Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/10/2026 ,inter alia, to consider and approve 1. Unaudited Financial Results of the Company for the Half yearly and quarter ended 30th September, 2026; 2. Any other business with the permission of Chairperson.

Reg Office: G2 & G3 Samarpan Complex, Next to Mirador Hotel, Chakala, Andheri East, Mumbai – 400099 Email Id: bacilpha@yahoo.com, CIN: L24200MH1987PLC043427, Tel: 22618452/22661541, Tel/Fax: 22618327 Date: 05th October, 2026 The Manager Listing Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort Mumbai-400001 Scrip Code: 524516 Dear Sir/Madam, Sub.: Intimation of Board Meeting under Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 29(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 14th October, 2026 to consider and approve, inter-alia, the following business: 1. Unaudited Financial Results of the Company for the Half yearly and quarter ended 30th September, 2026; 2. Any other business with the permission of Chairperson. Kindly take the above on record and acknowledge the receipt of the same. Thanking you, Yours faithfully, For Bacil Pharma Limited Chaitali Kalpataru Shah Managing Director Din: 11167778